Olaptesed Pegol

DB11707InvestigationalSmall molecule

Olaptesed Pegol has been investigated for the treatment of Hematopoietic Stem Cell Transplantation.

Mechanism: Pharmacologically active on Stromal cell-derived factor 1
Curator reviewed
Code names: NOX-A12

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

36Drug interactionsStructured to mechanism, not free text

7Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Olaptesed Pegol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.